Platinum(IV) compounds as potential drugs: a quantitative structure-activity relationship study.

Novak, Jurica; Zykova, Alena R; Potemkin, Vladimir A; Sharutin, Vladimir V; Sharutina, Olga K

Novak, Jurica; Zykova, Alena R; Potemkin, Vladimir A; Sharutin, Vladimir V; Sharutina, Olga K.

Afiliación

Novak J; Department of Biotechnology, University of Rijeka, Rijeka, Croatia.
Zykova AR; Center for Artificial Intelligence and Cyber security, University of Rijeka, Rijeka, Croatia.
Potemkin VA; Faculty of Chemistry, Department of Theoretical and Applied Chemistry, South Ural State University, Chelyabinsk, Russia.
Sharutin VV; Department of Biotechnology, University of Rijeka, Rijeka, Croatia.
Sharutina OK; Center for Artificial Intelligence and Cyber security, University of Rijeka, Rijeka, Croatia.

Bioimpacts ; 13(5): 373-382, 2023.

Article en En | MEDLINE | ID: mdl-37736338

Palabras clave

Drug repurposing; Generalized optimality criterion; Platinum(IV) complexes; RNA dependent RNA polymerase inhibitor; SARS-CoV

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Bioimpacts Año: 2023 Tipo del documento: Article País de afiliación: Croacia Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google